- Home
- SPHL vs CNSP Comparison
SPHL vs CNSP Comparison
Compare SPHL & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPHL
- CNSP
- Stock Information
- Founded
- SPHL 2002
- CNSP 2017
- Country
- SPHL Singapore
- CNSP United States
- Employees
- SPHL N/A
- CNSP N/A
- Industry
- SPHL Homebuilding
- CNSP Biotechnology: Pharmaceutical Preparations
- Sector
- SPHL Consumer Discretionary
- CNSP Health Care
- Exchange
- SPHL Nasdaq
- CNSP Nasdaq
- Market Cap
- SPHL 6.0M
- CNSP 5.6M
- IPO Year
- SPHL 2024
- CNSP 2019
- Fundamental
- Price
- SPHL $0.51
- CNSP $8.82
- Analyst Decision
- SPHL
- CNSP Hold
- Analyst Count
- SPHL 0
- CNSP 1
- Target Price
- SPHL N/A
- CNSP N/A
- AVG Volume (30 Days)
- SPHL 99.2K
- CNSP 27.0K
- Earning Date
- SPHL 02-21-2025
- CNSP 08-13-2025
- Dividend Yield
- SPHL N/A
- CNSP N/A
- EPS Growth
- SPHL N/A
- CNSP N/A
- EPS
- SPHL N/A
- CNSP N/A
- Revenue
- SPHL $6,456,601.00
- CNSP N/A
- Revenue This Year
- SPHL N/A
- CNSP N/A
- Revenue Next Year
- SPHL N/A
- CNSP N/A
- P/E Ratio
- SPHL N/A
- CNSP N/A
- Revenue Growth
- SPHL N/A
- CNSP N/A
- 52 Week Low
- SPHL $0.35
- CNSP $7.72
- 52 Week High
- SPHL $7.80
- CNSP $744.00
- Technical
- Relative Strength Index (RSI)
- SPHL N/A
- CNSP 37.72
- Support Level
- SPHL N/A
- CNSP $7.72
- Resistance Level
- SPHL N/A
- CNSP $9.62
- Average True Range (ATR)
- SPHL 0.00
- CNSP 0.86
- MACD
- SPHL 0.00
- CNSP -0.13
- Stochastic Oscillator
- SPHL 0.00
- CNSP 29.99
About SPHL Springview Holdings Ltd Class A Ordinary Shares
Springview Holdings Ltd is a company that conducts its operations through its indirect wholly-owned subsidiary which designs and constructs residential and commercial buildings in Singapore. It also provides four main types of works which includes new construction, reconstruction, Additions and Alterations (A&A), and other general contracting services such as renovation and design consultation. The company operates and manages its business as a single segment - in the development of construction projects. It derives maximum revenue from its Residential Customers.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.